Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP33573.RAXEYQB0QUK3VqFyXu2dZB9tKcTR4bHPGJCYmlhArQEuQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP33573.RAXEYQB0QUK3VqFyXu2dZB9tKcTR4bHPGJCYmlhArQEuQ130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP33573.RAXEYQB0QUK3VqFyXu2dZB9tKcTR4bHPGJCYmlhArQEuQ130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP33573.RAXEYQB0QUK3VqFyXu2dZB9tKcTR4bHPGJCYmlhArQEuQ130_provenance.
- NP33573.RAXEYQB0QUK3VqFyXu2dZB9tKcTR4bHPGJCYmlhArQEuQ130_assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33573.RAXEYQB0QUK3VqFyXu2dZB9tKcTR4bHPGJCYmlhArQEuQ130_provenance.
- NP33573.RAXEYQB0QUK3VqFyXu2dZB9tKcTR4bHPGJCYmlhArQEuQ130_assertion evidence source_evidence_curated NP33573.RAXEYQB0QUK3VqFyXu2dZB9tKcTR4bHPGJCYmlhArQEuQ130_provenance.
- NP33573.RAXEYQB0QUK3VqFyXu2dZB9tKcTR4bHPGJCYmlhArQEuQ130_assertion SIO_000772 21535412 NP33573.RAXEYQB0QUK3VqFyXu2dZB9tKcTR4bHPGJCYmlhArQEuQ130_provenance.
- NP33573.RAXEYQB0QUK3VqFyXu2dZB9tKcTR4bHPGJCYmlhArQEuQ130_assertion wasDerivedFrom ctd_human-20130708 NP33573.RAXEYQB0QUK3VqFyXu2dZB9tKcTR4bHPGJCYmlhArQEuQ130_provenance.
- NP33573.RAXEYQB0QUK3VqFyXu2dZB9tKcTR4bHPGJCYmlhArQEuQ130_assertion wasGeneratedBy ECO_0000218 NP33573.RAXEYQB0QUK3VqFyXu2dZB9tKcTR4bHPGJCYmlhArQEuQ130_provenance.
- ctd_human-20130708 importedOn "2013-07-24" NP33573.RAXEYQB0QUK3VqFyXu2dZB9tKcTR4bHPGJCYmlhArQEuQ130_provenance.